Graduate school

The University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

Retrieved on: 
Wednesday, November 30, 2022

University of Tokyo GSALS Associate Professor Masashi Soga has commented as follows regarding this joint research project.

Key Points: 
  • University of Tokyo GSALS Associate Professor Masashi Soga has commented as follows regarding this joint research project.
  • People have always turned to nature for relaxation and tranquility, and recent advances in research and technology have made it possible to quantify such intangible health benefits.
  • However, very little is known about the role played by biodiversity in providing these health benefits.
  • This joint research project is a large-scale investigation of how interacting with nature in our gardens, perhaps the most familiar nature to most of us, affects our health and well-being.

MHI Publishes Integrated Report "MHI Report 2022"

Retrieved on: 
Wednesday, November 30, 2022

TOKYO, Nov 30, 2022 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) today published the "MHI Report 2022."

Key Points: 
  • TOKYO, Nov 30, 2022 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) today published the "MHI Report 2022."
  • The focus of this year's integrated report is on MHI Group's contributions to global Carbon Neutrality.
  • The report opens with a message from the President and CEO Seiji Izumisawa outlining MHI Group's value creation proposal.
  • The MHI Report 2022 also contains a special feature on various measures being implemented by MHI Group toward realizing a carbon neutral world.

BIOMATRIX PROUDLY ANNOUNCES THE 2022 MEMORIAL SCHOLARSHIP RECIPIENTS

Retrieved on: 
Tuesday, November 29, 2022

PLANTATION, Fla., Nov. 29, 2022 /PRNewswire/ -- Each year, BioMatrix provides six $1,000 scholarships for bleeding disorders community members seeking higher education. Since 2013, our scholarships have honored the memory of several individuals who impacted the bleeding disorders community in unique ways. BioMatrix partners with the Hemophilia Federation of America for administrative support and independent, third-party evaluation of applicants.

Key Points: 
  • PLANTATION, Fla., Nov. 29, 2022 /PRNewswire/ -- Each year, BioMatrix provides six $1,000 scholarships for bleeding disorders community members seeking higher education.
  • BioMatrix partners with the Hemophilia Federation of America for administrative support and independent, third-party evaluation of applicants.
  • It is with great pleasure we announce the 2022 recipients of our Memorial Scholarship Program.
  • Without further ado, we introduce you to our scholarship recipients!

LECOM Opens New School of Podiatric Medicine

Retrieved on: 
Monday, November 28, 2022

ERIE, Pa., Nov. 28, 2022 /PRNewswire/ -- The Lake Erie College of Osteopathic Medicine (LECOM) announced it will open a new School of Podiatric Medicine (SPM). The LECOM-SPM Erie (PA) received approval from the accreditation agency, the Council on Podiatric Medical Education, to begin accepting students for the fall semester of 2023. The LECOM-SPM is the eleventh podiatric medical school in the United States. The four-year program will be located at LECOM's main campus in Erie, Pennsylvania and will offer a unique curricular collaboration with LECOM's College of Osteopathic Medicine.

Key Points: 
  • New school is the 11th podiatric medical school in the U.S. First class will begin in 2023
    ERIE, Pa., Nov. 28, 2022 /PRNewswire/ -- The Lake Erie College of Osteopathic Medicine (LECOM) announced it will open a new School of Podiatric Medicine (SPM).
  • The LECOM School of Podiatric Medicine is the eleventh podiatric medical school in the United States.
  • Dr. Lee earned his degree in podiatric medicine from Des Moines University College of Podiatric Medicine and Surgery.
  • Enrollment in the College of Osteopathic Medicine, School of Pharmacy, School of Dental Medicine, School of Podiatric Medicine, School of Health Services Administration and Graduate School of Biomedical Sciences has surpassed 4,400 students at campuses in Erie and Greensburg, Pa., Bradenton, Fla., and Elmira,
    N.Y. LECOM consistently graduates more primary care physicians than any other U.S. medical college while maintaining one of the lowest tuitions of any private medical school in the country.

Study Reports Similar Efficacy of Dynamic Digital Radiography of the Chest with Lung Ventilation Perfusion for Detection of Chronic Thromboembolic Pulmonary Hypertension

Retrieved on: 
Tuesday, November 22, 2022

Dynamic Digital Radiography is a radiographic technique that provides a series of individual digital X-ray images acquired at high speed and low radiation dose.

Key Points: 
  • Dynamic Digital Radiography is a radiographic technique that provides a series of individual digital X-ray images acquired at high speed and low radiation dose.
  • CTEPH is a complication of pulmonary embolism and a significant cause of pulmonary hypertension with associated morbidity and mortality if left untreated.
  • As a potentially treatable cause of pulmonary hypertension, identification of CTEPH with imaging may significantly impact clinical outcomes of patients with this condition.
  • Each patient also had conventional chest radiography and underwent a lung V/Q study on a SPECT/CT system with intravenous injection of technetium-99m macroaggregated albumin, 185 MBq.

Microbiome Sample Preparation Technology Market Report 2022: Rising Investments in Microbiome Research Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, November 21, 2022

The microbiome sample preparation technology market size is estimated to be USD 295.8 million in 2022 and is expected to witness a CAGR of 6.54% during the forecast period 2023-2033.

Key Points: 
  • The microbiome sample preparation technology market size is estimated to be USD 295.8 million in 2022 and is expected to witness a CAGR of 6.54% during the forecast period 2023-2033.
  • Rising investment for microbiome research, development of microbiome-based therapies, along with lowering sequencing costs, and continuous decline in the price of genomic testing are factors contributing to the market growth.
  • Rising investment for microbiome research is predicted to fuel the market growth.
  • The demand for microbiome sample preparation technology from academic and research institutions is projected to increase as grants and funding programmes for microbiome-based research are expanded.

Angelo State University Joins Growing Rank of Texas Institutions to Deploy YuJa Enterprise Video Platform Across Six Colleges and to Serve Over 10,000 Students

Retrieved on: 
Thursday, November 17, 2022

Part of the Texas Tech University System, Angelo State University (ASU) is among the newest Texas institutions to deploy the YuJa Enterprise Video Platform to serve its more than 10,000 students at six colleges.

Key Points: 
  • Part of the Texas Tech University System, Angelo State University (ASU) is among the newest Texas institutions to deploy the YuJa Enterprise Video Platform to serve its more than 10,000 students at six colleges.
  • The institution replaced two former video and content recording, editing and management products with YuJas single, unified platform.
  • YuJas suite of ed-tech products is growing in adoption throughout the state of Texas, which includes South Texas College, Dallas College, University of Texas at El Paso, Lamar University, McLennan Community College, Texas Wesleyan University, Clarendon College, Vernon College, Lone Star College, Texas State University, and others.
  • Angelo State University serves over 10,000 students and is part of the Texas Tech University System.

Lucy Therapeutics Expands Leadership Team with Appointment of Julia Gaebler, Ph.D., as Chief Business Officer

Retrieved on: 
Tuesday, November 15, 2022

Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer.

Key Points: 
  • Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer.
  • Dr. Gaebler has more than 25 years of business development and strategy experience in the life sciences industry, across biopharma, consulting, and academia.
  • View the full release here: https://www.businesswire.com/news/home/20221115005644/en/
    Dr. Gaebler will direct Lucy Therapeutics fundraising, growth and partnership activities for its promising proprietary preclinical compounds in Parkinsons disease, Rett syndrome, and other diseases of mitochondrial dysfunction.
  • Prior to joining Lucy Therapeutics, Dr. Gaebler was vice president of commercial strategy and portfolio planning at Milestone Pharmaceuticals and partner at Health Advances, a life-sciences strategy consulting firm.

Lingnan delegates host global congress in Glasgow and confirm further collaboration with Durham during recent Europe trip

Retrieved on: 
Monday, November 21, 2022

As well as hosting and participating in the congress, Lingnan delegates led by President Prof Leonard K Cheng and Vice-President Prof Joshua Mok Ka-ho, attended a number of academic exchange events, meetings and visits during their European trip.

Key Points: 
  • As well as hosting and participating in the congress, Lingnan delegates led by President Prof Leonard K Cheng and Vice-President Prof Joshua Mok Ka-ho, attended a number of academic exchange events, meetings and visits during their European trip.
  • A Memorandum of Understanding (MOU) with Durham University, UK, to increase inter-university cooperation in teaching and learning and research activities is one of the successful conclusions of the trip.
  • A global leader in Quality Education, Lingnan is strongly committed to supporting the UN's 17 Sustainable Development Goals (SDGs) through high impact research and collaboration with academic partners around the world.
  • Lingnan became a publicly funded institution in 1991 and was renamed Lingnan University (LU) in 1999.

Lingnan delegates host global congress in Glasgow and confirm further collaboration with Durham during recent Europe trip

Retrieved on: 
Monday, November 21, 2022

As well as hosting and participating in the congress, Lingnan delegates led by President Prof Leonard K Cheng and Vice-President Prof Joshua Mok Ka-ho, attended a number of academic exchange events, meetings and visits during their European trip.

Key Points: 
  • As well as hosting and participating in the congress, Lingnan delegates led by President Prof Leonard K Cheng and Vice-President Prof Joshua Mok Ka-ho, attended a number of academic exchange events, meetings and visits during their European trip.
  • A Memorandum of Understanding (MOU) with Durham University, UK, to increase inter-university cooperation in teaching and learning and research activities is one of the successful conclusions of the trip.
  • A global leader in Quality Education, Lingnan is strongly committed to supporting the UN's 17 Sustainable Development Goals (SDGs) through high impact research and collaboration with academic partners around the world.
  • Lingnan became a publicly funded institution in 1991 and was renamed Lingnan University (LU) in 1999.